As shown in Figs. 7B and S8A, Dox or DDP treatment led to upregulation of p21 levels in HCC cells, which could be enhanced by overexpression of CMTM6 and abolished by CMTM6 depletion. The gene discussed is CDKN1A; the disease is hepatocellular carcinoma.